Screening studies of transient elastography and FibroTest in the general population - Authors' reply.

Ginès P, Graupera I, Lammert F, Angeli P, Caballeria L …

MeSH — NLM indexing Elasticity Imaging Techniques Humans Liver Cirrhosis

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Fibrotest Actitest Letter Independent Group Spain

Authors (9)

Ginès P — Liver Unit, Hospital Clinic, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Centro d'Investigaciones Biomedicas en Red, Enfermedades Hepatologia y Digestivas (CIBEReHD), Barcelona, Spain. Electronic address: pgines@clinic.cat.
Graupera I — Liver Unit, Hospital Clinic, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Centro d'Investigaciones Biomedicas en Red, Enfermedades Hepatologia y Digestivas (CIBEReHD), Barcelona, Spain.
Lammert F — Department of Medicine II, Saarland University Medical Center, Homburg, Germany.
Angeli P — Unit of Hepatic Emergencies and Liver Transplantation, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Caballeria L — Centro d'Investigaciones Biomedicas en Red, Enfermedades Hepatologia y Digestivas (CIBEReHD), Barcelona, Spain; Unitat de Suport a la Recerca (USR) Metropolitana Nord, Institut d'Investigació en Atenció Primària (IDIAP) Jordi Gol, Barcelona, Spain.

Ginès P — Liver Unit, Hospital Clinic, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Centro d'Investigaciones Biomedicas en Red, Enfermedades Hepatologia y Digestivas (CIBEReHD), Barcelona, Spain. Electronic address: pgines@clinic.cat.
Graupera I — Liver Unit, Hospital Clinic, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Centro d'Investigaciones Biomedicas en Red, Enfermedades Hepatologia y Digestivas (CIBEReHD), Barcelona, Spain.
Lammert F — Department of Medicine II, Saarland University Medical Center, Homburg, Germany.
Angeli P — Unit of Hepatic Emergencies and Liver Transplantation, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Caballeria L — Centro d'Investigaciones Biomedicas en Red, Enfermedades Hepatologia y Digestivas (CIBEReHD), Barcelona, Spain; Unitat de Suport a la Recerca (USR) Metropolitana Nord, Institut d'Investigació en Atenció Primària (IDIAP) Jordi Gol, Barcelona, Spain.
Krag A — Department of Gastroenterology and Hepatology, Odense Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Guha IN — NIHR Nottingham Digestive Diseases Biomedical Research Unit, University of Nottingham, Nottingham, UK.
Murad SD — Department of Gastroenterology and Hepatology, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands.
Castera L — Department of Hepatology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France; Université Paris VII, INSERM UMR 1149, Centre de Recherche sur l'Inflammation, Paris, France.

Citation

Ginès P, Graupera I, Lammert F, Angeli P, Caballeria L, Krag A, et al. Screening studies of transient elastography and FibroTest in the general population - Authors' reply. Lancet Gastroenterol Hepatol. 2017;2(4):246-247. doi:10.1016/S2468-1253(17)30050-X.

Identifiers

DOI: 10.1016/S2468-1253(17)30050-X
PMID: 28404149

Tests

Liver diseases

Liver injuries

Comparisons

Subjects

Patient populations

Region

Screening studies of transient elastography and FibroTest in the general population - Authors' reply.

More on the same topic

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Toward non-invasive assessment strategies in autoimmune hepatitis.

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.

Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.